Immunova to Acquire AlphaTON Subsidiary Iox Therapeutics
Immunova has moved to acquire AlphaTON's cancer-treatment subsidiary, Iox Therapeutics, in a deal that signals a stra...
Safety is a key concern for investors. Learn which option, index funds or individual stocks, offers better security for your investments.
24,450 articlesImmunova has moved to acquire AlphaTON's cancer-treatment subsidiary, Iox Therapeutics, in a deal that signals a stra...
XRP has fallen roughly 60% from its July peak and sits near $1.45 as a wave of selling presses lower. Traders eye cri...
Visa extends its four-year partnership with Red Bull Racing, expanding branding and fan experiences amid lingering qu...
As Pool Corp closes its Q4, investors weigh the implications for pool corp (pool) 2025. This guide breaks down the ea...
Bitcoin often sparks heated debates about what it is really worth. This article argues the core mistake is treating p...
Target’s stock has surged 33% from October lows, prompting renewed questions about a possible buyout. This report ana...
Friday brought a notable rally for Integer Holdings as earnings beat and optimistic analyst updates boosted sentiment...
The Justice Department is broadening its antitrust review of Netflix’s Warner Bros. Discovery takeover to scrutinize ...
Fiserv is a payments and tech-enabled services giant that faced headwinds. This in-depth look breaks down the challen...
Stanley Martin Homes will acquire United Homes Group in an all-cash deal valued at $221 million, taking UHG private a...
A fresh AI-driven marketing platform launches a Reg A+ offering at $0.85 per share, claiming strong ROI through AI-po...
Navitas Semiconductor NVTS reports quarterly results that show revenue growth but ongoing margin pressure. Investors ...